Journal of Pain Research
Volume 16, 2023 - Issue
Open access
782
Views
4
CrossRef citations to date
0
Altmetric
REVIEW
A Review of the Therapeutic Targeting of SCN9A and Nav1.7 for Pain Relief in Current Human Clinical Trials
Anton Dormer1 Research and Development, Pepvax, Inc, Silver Spring, MD, USACorrespondence[email protected]
https://orcid.org/0000-0003-2432-8206View further author information
Mahesh Narayanan1 Research and Development, Pepvax, Inc, Silver Spring, MD, USAView further author information
, Jerome Schentag1 Research and Development, Pepvax, Inc, Silver Spring, MD, USAView further author information
, Daniel Achinko1 Research and Development, Pepvax, Inc, Silver Spring, MD, USAView further author information
, Elton Norman1 Research and Development, Pepvax, Inc, Silver Spring, MD, USAView further author information
, James Kerrigan2 Research and Development, Navintus, Inc, Princeton, NJ, USAView further author information
, Gary Jay2 Research and Development, Navintus, Inc, Princeton, NJ, USAView further author information
& William Heydorn2 Research and Development, Navintus, Inc, Princeton, NJ, USAView further author information
show all
Pages 1487-1498
|
Received 09 Sep 2022, Accepted 14 Mar 2023, Published online: 04 May 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.